Dennis Cho sold 14,205 shares of TWST at $89.75 under pre-arranged 10b5-1 plan; retains 105,141 shares.
This sale of 14,205 shares was executed under a 10b5-1 trading plan adopted on 2026-02-17, meaning it was scheduled rather than discretionary. The transaction occurred at $89.75, below the current price of $99.84 and the 52-week high of $104.23. While Twist Bioscience posted annual revenue growth of +20.3% and recent quarterly revenue of $110,715,000.00, the company reported net income of $-44,021,000.00 and remains unprofitable on a full-year basis. Cho retains 105,141 shares post-transaction, maintaining a substantial equity stake despite the scheduled disposition.